Home - Products - Others - Other Targets - 2,4-Dihydroxy-4,6-dimethoxydihydrochalcone

2,4-Dihydroxy-4,6-dimethoxydihydrochalcone

CAS No. 75679-58-2

2,4-Dihydroxy-4,6-dimethoxydihydrochalcone( —— )

Catalog No. M31356 CAS No. 75679-58-2

2,4-Dihydroxy-4,6-dimethoxydihydrochalcone is a natural product for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 684 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2,4-Dihydroxy-4,6-dimethoxydihydrochalcone
  • Note
    Research use only, not for human use.
  • Brief Description
    2,4-Dihydroxy-4,6-dimethoxydihydrochalcone is a natural product for research related to life sciences.
  • Description
    2,4-Dihydroxy-4,6-dimethoxydihydrochalcone is a natural product for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    75679-58-2
  • Formula Weight
    302.3
  • Molecular Formula
    C17H18O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Acetyl-(D-Arg10,Cys1...

    Ac-DArg-c[Cys-Glu-His-DPhe-Arg-Trp-Cys]-NH 2 is a cyclic octapeptide with MC4R agonism. Ac-DArg-c[Cys-Glu-His-DPhe-Arg-Trp-Cys]-NH 2 significantly increases heart rate and blood pressure.

  • Atezolizumab

    Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.

  • Isosalipurposide

    Isosalipurposide, a chalcone compound, exerts a cytoprotective effect against oxidative injury via Nrf2 activation.